Reduction of isoniazid bioavailability in normal men by concomitant intake of food. 1976

A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin

The influence of food intake on the bioavailability of isoniazid (INH) has been examined in nine healthy male volunteers. INH was administered as a single oral dose, both in fasting state and together with a standardized breakfast. Numerous venous blood samples were obtained 5 min-6 hours after the INH ingestion, and the concentrations of unmetabolized INH in serum were assessed by spectrophotometry. The observations indicate that both the peak concentration and the total amount of INH absorbed are greatly reduced when the drug is ingested together with food. Hence it is recommended that, in the treatment of tuberculosis with INH, the drug should be given on an empty stomach. The data may also have some bearing on the use of INH for assessing acetylation rates and estimating dosages of hydralazine and related drugs.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
December 1978, European journal of clinical pharmacology,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
June 1991, The Journal of the Association of Physicians of India,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
November 1984, International journal of clinical pharmacology, therapy, and toxicology,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
October 1985, Clinical pharmacology and therapeutics,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
April 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
July 1986, Clinical pharmacology and therapeutics,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
January 1981, Progress in clinical and biological research,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
November 1997, The American journal of clinical nutrition,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
January 1986, Applied research in mental retardation,
A Melander, and K Danielson, and A Hanson, and L Jansson, and J C Rerup, and B Scherstén, and T Thulin, and E Wåhlin
January 1985, Drug-nutrient interactions,
Copied contents to your clipboard!